• AchieveCE Reducing the Risk of ADHD

    Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder that has been diagnosed in up to 10% of school-age children in the US and frequently persists into adulthood. A study in a large Danish cohort found that ADHD was associated with higher mortality rates in children, adolescents, and adults, mainly due to accidents. Pharmacologic treatment of ADHD in children has been reported to decrease the risk of substance abuse in adolescents, and use of ADHD medications in adults has been associated with a reduced risk of serious traffic accidents and criminal behavior. This activity discusses how to reduce the risk of ADHD with PTBM and drugs approved by the FDA for treatment of ADHD.

    See full details chevron_right
    • Cost: $24
    • Credit hours: 2
    • CME credits awarded by: 2 AMA PRA Category 1 Credits™ by The Medical Letter and AchieveCE
    • Format: On-Demand Online